Back to Agency Updates
Health and Human Services DepartmentCenters for Disease Control and Prevention
  • By Learn Laws®
  • Published 05/12/2026
  • Updated 05/12/2026

Federal Agencies Seek Input on CDC's Expanded Respiratory Data Collection via NHSN


The Centers for Disease Control and Prevention (CDC) has announced a significant update to its data collection protocols for respiratory illnesses, inviting public comment on revisions to its National Healthcare Safety Network (NHSN) Respiratory Data project. Published in the Federal Register on May 12, 2026, this notice signals the agency's continued efforts to bolster its surveillance capabilities for diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The proposal, which seeks to refine how healthcare facilities report critical health data, falls under the purview of the Paperwork Reduction Act of 1995 and has a public comment deadline of July 13, 2026.

Background on NHSN Respiratory Data Collection

The NHSN serves as a critical national healthcare-associated infection tracking system, operated by the CDC's Division of Healthcare Quality Promotion (DHQP) within the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Its respiratory data component, specifically OMB Control Number 0920-1317, gathers information from healthcare facilities to provide "situational awareness" regarding the impact of prevalent respiratory diseases. This collection encompasses data on COVID-19, influenza, and RSV, enabling the CDC to identify trends at local, state, and national levels. The publicly available data complements other federal surveillance efforts, including wastewater monitoring, laboratory results, and emergency department visits. This integrated approach aims to create robust systems for threat detection and monitoring, keeping the public informed while also contributing to forecasting models for seasonal flu and COVID-19.

Proposed Revisions and Their Implications

The current Federal Register notice highlights a revision to an existing information collection previously approved in February 2026. This means the CDC is not initiating a completely new data collection but rather refining an ongoing one. Specifically, the proposed changes involve "revisions to 10 existing data collection forms." These modifications include "the addition, modification, or removal of certain questions," intended to enhance the quality, utility, and clarity of the collected information. While these adjustments are designed to improve data accuracy and relevance, they are projected to result in an increase in the estimated annual burden on reporting entities. The previous approval accounted for 1,558,384 burden hours, whereas this revision requests approval for an estimated annual burden of 1,697,390 hours. This represents a net increase of approximately 139,000 burden hours.

The Paperwork Reduction Act Context

Underpinning this entire process is the Paperwork Reduction Act of 1995 (PRA), a federal statute designed to minimize the paperwork burden on the public from federal information collections. The PRA mandates that all federal agencies obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. A critical component of this process is a mandatory 60-day public comment period in the Federal Register before submitting the collection to OMB for final approval. The OMB explicitly seeks public input on several key areas: the necessity and practical utility of the information, the accuracy of the agency's burden estimate, potential improvements to data quality and clarity, methods to minimize respondent burden (including technological solutions), and an assessment of collection costs. These requirements ensure a degree of transparency and public accountability in federal data gathering efforts.

Who Is Impacted and How

The revised data collection primarily impacts healthcare facilities, with various roles designated as respondents. The detailed burden table provided in the notice illustrates the estimated annual hours allocated across different types of personnel and reporting methods. Microbiologists, for instance, are expected to bear a significant portion of the reporting burden, whether through weekly or daily user entry, or by importing data via CSV files. Information Technology professionals also contribute, particularly when data is submitted through Application Programming Interfaces (APIs). The forms cover a wide range of reporting, from general hospital respiratory data to more specific modules like Point of Care Testing Results, Optional Person-Level Reporting for Long-Term Care Residents' vaccinations, and Healthcare Personnel COVID-19 Vaccination Summaries. The granular breakdown underscores the comprehensive nature of the NHSN data collection, touching various aspects of healthcare operations and public health surveillance. The cumulative increase in burden hours, while notable, is distributed across thousands of respondents and millions of individual responses annually, reflecting the widespread nature of the surveillance network.

The CDC's proposed revisions to its NHSN Respiratory Data collection signify an adaptive approach to public health surveillance. As the public health landscape continues to evolve, particularly in light of ongoing respiratory disease challenges, the accuracy and comprehensiveness of data become even more critical for informed decision-making. The open comment period provides an important opportunity for healthcare providers, public health professionals, and other stakeholders to offer insights that can shape the final implementation of these data collection efforts. Future debates may center on balancing the need for granular, timely data against the administrative burden on healthcare facilities, as well as ensuring the effective utilization of the collected information to generate actionable public health interventions. The outcome of this revision process will likely influence the efficiency and efficacy of national respiratory disease monitoring for years to come.

Learn More

We are an education company, not a law firm. The information and content we provide is for general informational purposes only and does not constitute legal advice. We make no representations, warranties, or guarantees regarding the accuracy, completeness, or applicability of the content. It is important to always consult with a qualified attorney for specific legal counsel pertaining to your individual circumstances.

People Also Viewed...

DOT Reasonable Suspicion Training for Supervisors

$60.00

Non-DOT Reasonable Suspicion Training for Supervisors

$55.00

Drug-Free Workplace Training for Employees

$35.00